Hepatitis C (HCV) Treatment and SVR: The Gap Between Clinical Trials and the Real-World

被引：0
|
作者：
Tahir, Madiha [1 ]
Alvi, Fatima [1 ]
Alam, Imtiaz [1 ]
机构：
[1] Austin Hepatitis Ctr, Austin, TX USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2014年 / 109卷
关键词：
D O I：
10.14309/00000434-201410002-00418
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
418
引用
收藏
页码：S125 / S125
页数：1
相关论文
共 50 条
  • [1] Hepatitis C treatment and SVR: the gap between clinical trials and real-world treatment aspirations
    North, Carol S.
    Hong, Barry A.
    Adewuyi, Sunday A.
    Pollio, David E.
    Jain, Mamta K.
    Devereaux, Robert
    Quartey, Nana A.
    Ashitey, Sarah
    Lee, William M.
    Lisker-Melman, Mauricio
    GENERAL HOSPITAL PSYCHIATRY, 2013, 35 (02) : 122 - 128
  • [2] Hepatitis C (HCV) Treatment and SVR12: The Gap Between Clinical Trials and Community Practice with DAA Therap
    Anjum, Sarah
    Sultan, Taha
    Tariq, Zohha
    Alam, Imtiaz
    HEPATOLOGY, 2017, 66 : 828A - 829A
  • [3] Hepatitis C (HCV) Treatment and SVR12: The Gap Between Clinical Trials and Community Practice With DAA Therapy
    Anjum, Sarah
    Sultan, Taha
    Tariq, Zohha
    Alam, Imtiaz
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S576 - S576
  • [4] The gap between registration trials and real world in hepatitis C is closing
    Berden, Floor A. C.
    Vuik, Fanny E. R.
    Drenth, Joost P. H.
    Kievit, Wietske
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (04) : 455 - 456
  • [5] Real-world data: bridging the gap between clinical trials and practice
    Wilson, Brooke E.
    Booth, Christopher M.
    ECLINICALMEDICINE, 2024, 78
  • [6] Efficacy and Effectiveness: Bridging the Gap Between Clinical Trials and Real-world Practice
    Nguyen, David-Dan
    Satkunasivam, Raj
    Wallis, Christopher J. D.
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (01): : 25 - 26
  • [7] Real-world effectiveness and cost per svr of sofosbuvir/velpatasvir chronic hepatitis c treatment
    Buggisch, Peter
    Atanasov, Petar
    Wursthorn, Karsten
    Stoehr, Albrecht
    Petersen, Joerg
    HEPATOLOGY, 2017, 66 : 856A - 856A
  • [8] Real-world effectiveness and cost per SVR of ledipasvir/sofosbuvir chronic hepatitis C treatment
    Buggisch, Peter
    Wursthorn, Karsten
    Stoehr, Albrecht
    Gauthier, Aline
    Atanasov, Petar K.
    Petersen, Joerg
    HEPATOLOGY, 2015, 62 : 791A - 791A
  • [9] Real-world effectiveness and cost per SVR of Sofosbuvir/Velpatasvir chronic hepatitis C treatment
    Buggisch, P.
    Atanasov, P.
    Wursthorn, K.
    Stoehr, A.
    Petersen, J.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S730 - S730
  • [10] HEPATITIS C - REAL WORLD EFFECTIVENESS OF HCV TREATMENT IN POLAND
    Plisko, R.
    Wladysiuk, M.
    Miazga, P.
    Bebrysz, M.
    VALUE IN HEALTH, 2016, 19 (07) : A408 - A408
12345